eicosapentaenoic acid ethyl ester has been researched along with Dementia in 2 studies
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stilling, F | 1 |
| Wolk, A | 1 |
| Religa, D | 1 |
| Leppert, J | 1 |
| Bergkvist, L | 1 |
| Michaëlsson, K | 1 |
| Larsson, SC | 1 |
| Coley, N | 1 |
| Raman, R | 1 |
| Donohue, MC | 1 |
| Aisen, PS | 1 |
| Vellas, B | 1 |
| Andrieu, S | 1 |
2 other studies available for eicosapentaenoic acid ethyl ester and Dementia
| Article | Year |
|---|---|
Adipose tissue fatty acid composition and cognitive impairment.
Topics: Adipose Tissue; Aged, 80 and over; Arachidonic Acid; Cognitive Dysfunction; Cross-Sectional Studies; | 2018 |
Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Topics: Activities of Daily Living; Aged; Cognition; Cognitive Dysfunction; Dementia; Dietary Supplements; D | 2018 |